142 related articles for article (PubMed ID: 20948310)
1. eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways.
Shahbazian D; Parsyan A; Petroulakis E; Hershey J; Sonenberg N
Cell Cycle; 2010 Oct; 9(20):4106-9. PubMed ID: 20948310
[TBL] [Abstract][Full Text] [Related]
2. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.
Modelska A; Turro E; Russell R; Beaton J; Sbarrato T; Spriggs K; Miller J; Gräf S; Provenzano E; Blows F; Pharoah P; Caldas C; Le Quesne J
Cell Death Dis; 2015 Jan; 6(1):e1603. PubMed ID: 25611378
[TBL] [Abstract][Full Text] [Related]
3. Backbone resonance assignments of the C-terminal region of human translation initiation factor eIF4B.
Mondal S; Rousseau S; Talenton V; Thiam CAB; Aznauryan M; Mackereth CD
Biomol NMR Assign; 2023 Dec; 17(2):199-203. PubMed ID: 37368134
[TBL] [Abstract][Full Text] [Related]
4. Regulation of mRNA translation by signaling pathways.
Roux PP; Topisirovic I
Cold Spring Harb Perspect Biol; 2012 Nov; 4(11):. PubMed ID: 22888049
[TBL] [Abstract][Full Text] [Related]
5. Activation and up-regulation of translation initiation factor 4B contribute to arsenic-induced transformation.
Zhang Y; Wang Q; Guo X; Miller R; Guo Y; Yang HS
Mol Carcinog; 2011 Jul; 50(7):528-38. PubMed ID: 21268130
[TBL] [Abstract][Full Text] [Related]
6. PARK2 regulates eIF4B-driven lymphomagenesis.
Kapadia BB; Roychowdhury A; Kayastha F; Nanaji N; Gartenhaus RB
Mol Cancer Res; 2022 Feb; 20(5):735-48. PubMed ID: 35191952
[TBL] [Abstract][Full Text] [Related]
7. PARK2 regulates eIF4B-driven lymphomagenesis.
Kapadia BB; Roychowdhury A; Kayastha F; Nanaji N; Gartenhaus RB
Mol Cancer Res; 2022 Feb; ():. PubMed ID: 35105670
[TBL] [Abstract][Full Text] [Related]
8. Translational alterations in pancreatic cancer: a central role for the integrated stress response.
Shin S; Solorzano J; Liauzun M; Pyronnet S; Bousquet C; Martineau Y
NAR Cancer; 2022 Dec; 4(4):zcac031. PubMed ID: 36325577
[TBL] [Abstract][Full Text] [Related]
9. A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.
Horvilleur E; Sbarrato T; Hill K; Spriggs RV; Screen M; Goodrem PJ; Sawicka K; Chaplin LC; Touriol C; Packham G; Potter KN; Dirnhofer S; Tzankov A; Dyer MJ; Bushell M; MacFarlane M; Willis AE
Leukemia; 2014 May; 28(5):1092-102. PubMed ID: 24135829
[TBL] [Abstract][Full Text] [Related]
10. eIF4B stimulates translation of long mRNAs with structured 5' UTRs and low closed-loop potential but weak dependence on eIF4G.
Sen ND; Zhou F; Harris MS; Ingolia NT; Hinnebusch AG
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10464-72. PubMed ID: 27601676
[TBL] [Abstract][Full Text] [Related]
11. eIF4B phosphorylation by pim kinases plays a critical role in cellular transformation by Abl oncogenes.
Yang J; Wang J; Chen K; Guo G; Xi R; Rothman PB; Whitten D; Zhang L; Huang S; Chen JL
Cancer Res; 2013 Aug; 73(15):4898-908. PubMed ID: 23749639
[TBL] [Abstract][Full Text] [Related]
12. Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis.
Dennis MD; Jefferson LS; Kimball SR
J Biol Chem; 2012 Dec; 287(51):42890-9. PubMed ID: 23105104
[TBL] [Abstract][Full Text] [Related]
13. mRNA helicases: the tacticians of translational control.
Parsyan A; Svitkin Y; Shahbazian D; Gkogkas C; Lasko P; Merrick WC; Sonenberg N
Nat Rev Mol Cell Biol; 2011 Apr; 12(4):235-45. PubMed ID: 21427765
[TBL] [Abstract][Full Text] [Related]
14. FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM.
Watanabe D; Nogami A; Okada K; Akiyama H; Umezawa Y; Miura O
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31756944
[TBL] [Abstract][Full Text] [Related]
15. In vitro RNA selection identifies RNA ligands that specifically bind to eukaryotic translation initiation factor 4B: the role of the RNA remotif.
Methot N; Pickett G; Keene JD; Sonenberg N
RNA; 1996 Jan; 2(1):38-50. PubMed ID: 8846295
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B.
Xu J; Lu Y; Liu Q; Xia A; Zhao J; Xu X; Sun Q; Qi F; Sun B
Cancer Lett; 2020 Mar; 473():1-12. PubMed ID: 31875526
[TBL] [Abstract][Full Text] [Related]
17. EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling.
Hu Z; Chen PH; Li W; Krone M; Zheng S; Saarbach J; Velasco IU; Hines J; Liu Y; Crews CM
Sci Adv; 2024 Mar; 10(13):eadj7251. PubMed ID: 38536914
[TBL] [Abstract][Full Text] [Related]
18. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
[TBL] [Abstract][Full Text] [Related]
19. Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder.
Ruggiero V; Fagioli C; de Pretis S; Di Carlo V; Landsberger N; Zacchetti D
Front Cell Neurosci; 2023; 17():1231493. PubMed ID: 37964795
[TBL] [Abstract][Full Text] [Related]
20. Curcumin analog GO-Y030 inhibits tumor metastasis and glycolysis.
MaruYama T; Miyazaki H; Komori T; Osana S; Shibata H; Owada Y; Kobayashi S
J Biochem; 2023 Nov; 174(6):511-518. PubMed ID: 37656908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
